Risk factors for intrahepatic recurrence of hepatocellular carcinoma in cirrhotic patients treated by percutaneous ethanol injection

Cancer

Volumn 79, Issue 8, 1997, Pages 1501-1508

  Pompili, Maurizio ^a   Rapaccini, Gian Ludovico ^a   De Luca, Francescantonio ^a   Caturelli, Eugenio ^b   Astone, Antonio ^a   Siena, Domenico Angelo ^b   Villani, Maria Rosaria ^b   Grattagliano, Anna ^a   Cedrone, Augusto ^a   Gasbarrini, Giovanni ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

Author keywords

cirrhosis; hepatocellular carcinoma; long term survival; percutaneous ethanol injection; recurrence rate

Indexed keywords

ALANINE AMINOTRANSFERASE; ALCOHOL; ASPARTATE AMINOTRANSFERASE; HEPATITIS B SURFACE ANTIGEN;

ADULT; AGED; ALCOHOLISM; ARTICLE; CANCER RECURRENCE; FEMALE; FOLLOW UP; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECURRENCE RISK; RISK FACTOR; SCORING SYSTEM;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; CARCINOMA, HEPATOCELLULAR; ETHANOL; FEMALE; FOLLOW-UP STUDIES; HUMANS; ITALY; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASMS, SECOND PRIMARY; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 0030898063     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19970415)79:8<1501::AID-CNCR9>3.0.CO;2-D     Document Type: Article

References (34)

1. Scudamore CH, Ragaz J, Klutfinger AM, Owen DA. Hepatocellular carcinoma. A comparison of oriental and caucasian patients. Am J Surg 1988; 155:659-62.
2. Wong F, Choi TK. Primary liver cancer. Asian experience. In: Blumgart LH, editor. Surgery of liver and biliary tract. London: Churchill-Livingstone, 1988:1135-51.
3. Tiribelli C, Croce LS, Polo S, Sodde M, Stanta G. Incidence of HCC in Italy. What could we learn from autoptic studies? Ital J Gastroenterol 1991;23:448-51.
4. Okuda K, Fujimoto I, Hanai A, Urano Y. Changing incidence of hepatocellular carcinoma in Japan. Cancer Res 1987; 47:4967-72.
5. Sherlock S. Viruses and hepatocellular carcinoma. Gut 1994;35:828-32.
6. Okuda K. Hepatocellular carcinoma: recent progress. Hepatology 1992; 15:948-63.
7. Colombo M, De Franchis R, Del Ninno E, Sangiovanni A, De Fazio C, Tommasini M, et al. Hepatocellular carcinoma in Italian patients with cirrhosis N Engl J Med 1991;325:675-80.
8. Benvegnù L, Fattovich G, Noventa F, Tremolada F, Chemello L, Cecchetto A, et al. Concurrent hepatitis B and C virus infection and risk of hepatocellular carcinoma in cirrhosis. A prospective study. Cancer 1994;74:2441-8.
9. Imberti D, Fornari F, Sbolli G, Buscarini E, Squassante L, Buscarini L, Hepatocellular carcinoma in liver cirrhosis. A prospective study. Scand J Gastroenterol 1993;28:540-4.
10. The liver cancer study group of Japan. Predictive factors for long term prognosis after partial hepatectomy for patients with hepatocellular carcinoma in Japan. Cancer 1994; 74:2772-80.
11. Livraghi T, Giorgio A, Marin G, Salmi A, de Sio I, Bolondi L, et al. Hepatocellular carcinoma and cirrhosis in 746 patients: long-term results of percutaneous ethanol injection. Radiology 1995;197:101-8.
12. Adachi E, Maeda T, Matsumata T, Shirabe K, Kinukawa N, Sugimachi K, et al. Risk factors for intrahepatic recurrence in human small hepatocellular carcinoma. Gastroenterology 1995;108:768-75.
13. Nagashima I, Hamada C, Naruse K, Osada T, Nagao T, Kawano N, et al. Surgical resection for small hepatocellular carcinoma. Surgery 1996;118:40-5.
14. Ikeda K, Saitoh S, Tsubota A, Arase Y, Chayama K, Kumada H, et al. Risk factors for tumor recurrence and prognosis after curative resection of hepatocellular carcinoma. Cancer 1993;71:19-25.
15. Belghiti J, Panis Y, Farges O, Benhamou JP, Fekete F. Intrahepatic recurrence after resection of hepatocellular carcinoma complicating cirrhosis. Ann Surg 1991;214:114-7.
16. Shiina S, Tagawa K, Niwa Y, Unuma T, Komatsu Y, Yoshiura K, et al. Percutaneous ethanol injection therapy for hepatocellular carcinoma: results in 146 patients. AJR Am J Roentgenol 1993;160:1023-8.
17. Pugh RNH, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the esophagus for bleeding esophageal varices. Br J Surg 1973;60:646-9.
18. Rapaccini GL, Pompili M, Caturelli E, Fusilli S, Trombino C, Gomes V, et al. Ultrasound-guided fine-needle biopsy of hepatocellular carcinoma: comparison between smear cytology and microhistology. Am J Gastroenterol 1994;89:898-902.
19. Edmondson HA, Steiner PE. Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies. Cancer 1954;7:462-503.
20. Cedrone A, Rapaccini GL, Pompili M, Aliotta A, Trombino C, de Luca F, et al. Portal vein thrombosis complicating hepatocellular carcinoma. Value of ultrasound-guided fine-needle biopsy of the thrombus in the therapeutic management. Liver 1996; 19:94-8.
21. Kaplan EL, Meier P. Non parametric estimations from incomplete observations. J Am Stat Assoc 1958;53:457-81.
22. Ishii H, Okada S, Nose H, Okusaka T, Yoshimori M, Takayama T, et al. Local recurrence of hepatocellular carcinoma after percutaneous ethanol injection. Cancer 1996;77:1792-6.
23. Chiu GH, Wu LH, Kao HL, Chang HM, Tsay SH, Loong CC, et al. Can determination of the proliferating capacity of the nontumor portion predict the risk of tumor recurrence in the liver remnant after resection of human hepatocellular carcinoma? Hepatology 1993;18:96-102.
24. Muto Y, Moriwaki H, Ninomiya M, Adachi S, Saito A, Takasaki KT, et al. Prevention of second primary tumors by an acyclic retinoid, polyprenoic acid in patients with hepatocellular carcinoma. N Engl J Med 1996;334:1561-7.
25. Ikeda K, Saitoh S, Koida I, Arase Y, Tsubota A, Chayama K, et al. A multivariate analysis of risk factors for hepatocellular carcinogenesis: a prospective observation of 795 patients with viral and alcoholic cirrhosis. Hepatology 1993;18:47-53.
26. Taketa K. Alpha-fetoprotein: reevaluation in hepatology. Hepatology 1990;12:1420-31.
27. Nagasue N, Inokuchi K, Kobayashi M, Kanashima R. Serum alpha-fetoprotein in patients following partial hepatectomy. Dig Dis Sci 1980;25:243-7.
28. Ebara M, Ohto M, Shinagawa T, Sugiura N, Kimura K, Matsutani S, et al. Natural history of minute hepatocellular carcinoma smaller than 3 centimeters complicating cirrhosis: a study in 22 patients. Gastroenterology 1986;90:289-98.
29. Sheu JC, Sung JL, Chen DS, Yang PM, Lai MY, Lee CS, et al. Growth rate of asymptomatic hepatocellular carcinoma and its clinical implications. Gastroenterology 1985;89:259-66.
30. Shinagawa T, Ohto M, Kimura K, Tsunetomi S, Morita M, Saisho H, et al. Diagnosis and clinical features of small hepatocellular carcinoma with emphasis on the utility of realtime ultrasonography: a study in 51 patients. Gastroenterology 1984;86:495-502.
31. Sonoda K, Shirabe K, Takenaka K, Kanematsu T, Yasumori K, Sugimachi K. Angiographically undetected small hepatocellular carcinoma: clinicopathological characteristics, follow-up and treatment. Hepatology 1989;10:1003-7.
32. Okuda K. Early recognition of hepatocellular carcinoma. Hepatology 1986;6:729-38.
33. Imaeda T, Doi H. A retrospective study on the pattern of sequential fluctuation of serum alpha-fetoprotein level during progression from liver cirrhosis to hepatocellular carcinoma. J Gastroenterol Hepatol 1992;7:132-5.
34. Ishii H, Okada S, Nose H, Okusaka T, Nagahama H, Nakayama H, et al. Predictive factors for recurrence after percutaneous ethanol injection for solitary hepatocellular carcinoma. Hepatogastroenterology 1996;43:938-43.